156 related articles for article (PubMed ID: 34695225)
1. Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation.
Huang H; Liu M; Ren J; Hu J; Lin S; Li D; Huang W; Chen S; Yang T; Wu X
J Clin Pharmacol; 2022 May; 62(5):609-619. PubMed ID: 34695225
[TBL] [Abstract][Full Text] [Related]
2. External Evaluation of Population Pharmacokinetic Models of Busulfan in Chinese Adult Hematopoietic Stem Cell Transplantation Recipients.
Huang H; Liu Q; Zhang X; Xie H; Liu M; Chaphekar N; Wu X
Front Pharmacol; 2022; 13():835037. PubMed ID: 35873594
[No Abstract] [Full Text] [Related]
3. Population pharmacokinetics analysis of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation.
Wu X; Xie H; Lin W; Yang T; Li N; Lin S; Yuan X; Ren J; Li X; Huang X
Clin Exp Pharmacol Physiol; 2017 May; 44(5):529-538. PubMed ID: 28135768
[TBL] [Abstract][Full Text] [Related]
4. Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study.
Ben Hassine K; Nava T; Théoret Y; Nath CE; Daali Y; Kassir N; Lewis V; Bredius RGM; Shaw PJ; Bittencourt H; Krajinovic M; Uppugunduri CRS; Ansari M
CPT Pharmacometrics Syst Pharmacol; 2021 Sep; 10(9):1043-1056. PubMed ID: 34453497
[TBL] [Abstract][Full Text] [Related]
5. Systematic external evaluation of reported population pharmacokinetic models of vancomycin in Chinese children and adolescents.
Lv C; Lu J; Jing L; Liu TT; Chen M; Zhang R; Li C; Zhou S; Wei Y; Chen Y
J Clin Pharm Ther; 2021 Jun; 46(3):820-831. PubMed ID: 33751618
[TBL] [Abstract][Full Text] [Related]
6. Pediatric patients undergoing hematopoietic stem cell transplantation can greatly benefit from a novel once-daily intravenous busulfan dosing nomogram.
Rhee SJ; Lee JW; Yu KS; Hong KT; Choi JY; Hong CR; Park KD; Shin HY; Song SH; Kang HJ; Lee H
Am J Hematol; 2017 Jul; 92(7):607-613. PubMed ID: 28370238
[TBL] [Abstract][Full Text] [Related]
7. Predictive performance of a busulfan pharmacokinetic model in children and young adults.
Bartelink IH; van Kesteren C; Boelens JJ; Egberts TC; Bierings MB; Cuvelier GD; Wynn RF; Slatter MA; Chiesa R; Danhof M; Knibbe CA
Ther Drug Monit; 2012 Oct; 34(5):574-83. PubMed ID: 22972539
[TBL] [Abstract][Full Text] [Related]
8. Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study.
Xu B; Yang T; Zhou J; Zheng Y; Wang J; Liu Q; Li D; Zhang Y; Liu M; Wu X
CPT Pharmacometrics Syst Pharmacol; 2023 Sep; 12(9):1238-1249. PubMed ID: 37491812
[TBL] [Abstract][Full Text] [Related]
9. Optimization of Busulfan Dosing Regimen in Pediatric Patients Using a Population Pharmacokinetic Model Incorporating GST Mutations.
Yuan J; Sun N; Feng X; He H; Mei D; Zhu G; Zhao L
Pharmgenomics Pers Med; 2021; 14():253-268. PubMed ID: 33623415
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic analysis of intravenous busulfan: GSTA1 genotype is not a predictive factor of initial dose in Chinese adult patients undergoing hematopoietic stem cell transplantation.
Sun Y; Huang J; Hao C; Li Z; Liang W; Zhang W; Chen B; Yang W; Hu J
Cancer Chemother Pharmacol; 2020 Feb; 85(2):293-308. PubMed ID: 31834435
[TBL] [Abstract][Full Text] [Related]
11. External evaluation of published population pharmacokinetic models of polymyxin B.
Li YQ; Chen KF; Ding JJ; Tan HY; Yang N; Lin YQ; Wu CF; Xie YL; Yang GP; Liu JJ; Pei Q
Eur J Clin Pharmacol; 2021 Dec; 77(12):1909-1917. PubMed ID: 34342716
[TBL] [Abstract][Full Text] [Related]
12. Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.
Zhang HX; Sheng CC; Liu LS; Luo B; Fu Q; Zhao Q; Li J; Liu YF; Deng RH; Jiao Z; Wang CX
Br J Clin Pharmacol; 2019 Apr; 85(4):746-761. PubMed ID: 30597603
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.
Nava T; Kassir N; Rezgui MA; Uppugunduri CRS; Huezo-Diaz Curtis P; Duval M; Théoret Y; Daudt LE; Litalien C; Ansari M; Krajinovic M; Bittencourt H
Br J Clin Pharmacol; 2018 Jul; 84(7):1494-1504. PubMed ID: 29469189
[TBL] [Abstract][Full Text] [Related]
14. Population Pharmacokinetic Evaluation with External Validation of Tacrolimus in Chinese Primary Nephrotic Syndrome Patients.
Yang L; Yang N; Yi B; Pei Q; Huang Z
Pharm Res; 2022 Aug; 39(8):1907-1920. PubMed ID: 35650450
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use.
Long-Boyle JR; Savic R; Yan S; Bartelink I; Musick L; French D; Law J; Horn B; Cowan MJ; Dvorak CC
Ther Drug Monit; 2015 Apr; 37(2):236-45. PubMed ID: 25162216
[TBL] [Abstract][Full Text] [Related]
16. External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.
Zhao CY; Jiao Z; Mao JJ; Qiu XY
Br J Clin Pharmacol; 2016 May; 81(5):891-907. PubMed ID: 26574188
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients.
Wang D; Chen X; Xu H; Li Z
Xenobiotica; 2020 Feb; 50(2):178-185. PubMed ID: 30938547
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of busulfan in Saudi pediatric patients undergoing hematopoietic stem cell transplantation.
Alsultan A; Albassam AA; Alturki A; Alsultan A; Essa M; Almuzzaini B; Alfadhel S
Int J Clin Pharm; 2020 Apr; 42(2):703-712. PubMed ID: 32140913
[TBL] [Abstract][Full Text] [Related]
19. External evaluation of population pharmacokinetic models for ciclosporin in adult renal transplant recipients.
Mao JJ; Jiao Z; Yun HY; Zhao CY; Chen HC; Qiu XY; Zhong MK
Br J Clin Pharmacol; 2018 Jan; 84(1):153-171. PubMed ID: 28891596
[TBL] [Abstract][Full Text] [Related]
20. Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients.
Cai X; Li R; Sheng C; Tao Y; Zhang Q; Zhang X; Li J; Shen C; Qiu X; Wang Z; Jiao Z
Eur J Pharm Sci; 2020 Mar; 145():105237. PubMed ID: 32001346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
